Bio-Rad Laboratories BIO Total debt

Total debt at other companies

AbbottABT

$32.61B+143%

Becton, Dickinson and CompanyBDX

$13.51B-22.9%

Thermo Fisher ScientificTMO

$39.18B+4.6%

DanaherDHR

$27.86B+50.1%

MaxCyteMXCT

$17.49M-7.1%

Quanterix CorporationQTRX

$35.34M-2.9%

FAQ

What is Bio-Rad Laboratories's total debt?

Bio-Rad Laboratories (BIO) reported total debt of $987.3M in Q1 2026.

How has Bio-Rad Laboratories's total debt changed year-over-year?

Bio-Rad Laboratories's total debt decreased by 28.4% year-over-year, from $1.38B to $987.3M.

What is the long-term trend for Bio-Rad Laboratories's total debt?

Over 5 years (2020 to 2025), Bio-Rad Laboratories's total debt has grown at a 42.7% compound annual growth rate (CAGR), from $235.86M to $1.39B.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.